Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.cophys.2021.03.005 http://scihub22266oqcxt.onion/10.1016/j.cophys.2021.03.005 33817453!7997144!33817453     free     free     free       Curr+Opin+Physiol 2021 ; 21 (ä): 29-35 Nephropedia Template TP {{tp|p=33817453|t=2021. Pulmonary function and COVID-19 |pdf=|usr=}}{{33817453}} gab.com Text Pulmonary function and COVID-19 JO: Curr Opin Physiol http://www.kidney.de/pget.php?&tw=1&pmid=33817453 #FOAvip In people recovering from COVID-19, there is concern regarding potential long-term pulmonary sequelae and associated impairment of functional capacity. Data published thus far indicate that spirometric indices appear to be generally well preserved, but that a defect in diffusing capacity (DLco) is a prevalent abnormality identified on follow-up lung function; present in 20-30% of those with mild to moderate disease and 60% in those with severe disease. Reductions in total lung capacity were commonly reported. Functional capacity is also often impaired, with data now starting to emerge detailing walk test and cardiopulmonary exercise test outcome at follow-up. In this review, we evaluate the published evidence in this area, to summarise the impact of COVID-19 infection on pulmonary function and relate this to the clinico-radiological findings and disease severity. Twit Text FOAVip Pulmonary function and COVID-19 ????Curr Opin Physiol http://www.kidney.de/pget.php?&tw=1&pmid=33817453 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33817453 #FOAvip English Wikipedia <ref>{{Cite pmid|33817453}}</ref> Pulmonary function and COVID-19 #MMPMID33817453 Thomas M; Price OJ; Hull JH Curr Opin Physiol 2021[Jun]; 21 (ä): 29-35 PMID33817453show ga In people recovering from COVID-19, there is concern regarding potential long-term pulmonary sequelae and associated impairment of functional capacity. Data published thus far indicate that spirometric indices appear to be generally well preserved, but that a defect in diffusing capacity (DLco) is a prevalent abnormality identified on follow-up lung function; present in 20-30% of those with mild to moderate disease and 60% in those with severe disease. Reductions in total lung capacity were commonly reported. Functional capacity is also often impaired, with data now starting to emerge detailing walk test and cardiopulmonary exercise test outcome at follow-up. In this review, we evaluate the published evidence in this area, to summarise the impact of COVID-19 infection on pulmonary function and relate this to the clinico-radiological findings and disease severity. äPulmonary function and COVID-19 (epmc).pdf DeepDyve Pubget Overpricing